跳至主要内容
临床试验/NCT05993585
NCT05993585招募中不适用

The Effects of Cardiac Resynchronisation Therapy on the Frank Starling Mechanism in Patients With Heart Failure

Guy's and St Thomas' NHS Foundation Trust2 个研究点 分布在 1 个国家目标入组 40 人开始时间: 2024年1月15日最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
招募中
入组人数
40
试验地点
2
主要终点
Difference in starling mechanism

研究概览

简要总结

The investigators are examining a scientific principle called the Frank Starling Mechanism and how it relates to Cardiac Resynchronisation Therapy (CRT), a form of pacemaker therapy used in the treatment of heart failure.

The Frank Starling Mechanism is an established biological principle. The law states that the stroke volume of the heart increases in response to an increase in the volume of blood in the ventricles, before contraction, when all other factors remain constant. In other words, the law states that the more blood enters the heart, the more blood is pumped out of the heart with any given beat.

There is some evidence that in some patients with chronic heart conditions, the Frank Starling Mechanism is LESS EFFECTIVE, meaning that the heart is less able to cope with a reduction in heart pumping function over time. There is also evidence that treatment with CRT may IMPROVE the Frank Starling Mechanism - evidence for this has been shown in dog and mice hearts, however, has never been shown in humans.

The investigators aim to conduct a study where subjects undergo an ultrasound scan of the heart (echocardiogram) whilst the participants pacemaker settings are temporarily changed. This allows the investigators to measure the pumping function of the heart as more blood enters the heart. The investigators will perform this test on 20 participants before and after CRT, as well as 20 participants who have pacemakers, but no heart failure. This study aims to test 3 hypotheses.

  1. In participants with pacemakers, a REDUCED Frank Starling Mechanism predicts which participants go on to develop heart failure.
  2. Treatment with CRT IMPROVES the Frank Starling Mechanism in participants with pacemakers and heart failure.
  3. The degree of improvement of the Frank Starling Mechanism after treatment with CRT predicts which participants will respond to this treatment.

详细描述

The primary research investigation in this study is a non-invasive test of the Frank Starling mechanism, which involves performing a transthoracic echocardiogram (ultrasound scan of the heart) whilst temporarily changing pacemaker settings to mimic conditions such as faster heart rates or increased blood flow to the heart. Measurements taken from the echocardiogram during these changes in pacemaker settings will be used to determine the effectiveness of the heart's Starling Mechanism. This test will last between 20-40 minutes. No special preparation is needed and participants will be able to go home immediately afterwards. Pacemaker settings will be returned to normal once the test is completed.

研究设计

研究类型
Interventional
分配方式
Non Randomized
干预模型
Parallel
主要目的
Basic Science
盲法
None

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • • Ability to provide informed consent to participate and willing to comply with the clinical investigation plan and follow-up schedule.
  • Existing dual chamber pacemaker or ICD including atrial lead and RV lead.
  • RV pacing percentage >40%.
  • CRT group - Severe left ventricular systolic impairment (LVEF≤35%). Clinical symptoms of heart failure despite optimum medical therapy (NYHA class II-IV).
  • Control group - LVEF >50%.

排除标准

  • • Previous treated with CRT (existing LV lead/His-Bundle lead/Left Bundle Branch Area lead).
  • Persistent atrial fibrillation
  • Female participants who are pregnant, lactating or planning pregnancy during the course of the study.
  • Participation in other studies with active treatment / investigational arm

研究组 & 干预措施

CRT Group

Experimental

CRT group: We will include patients with symptomatic heart failure (LV ejection fraction <35% on TTE, NYHA II-IV) and an RV pacing percentage of >40%, thus meeting ESC Criteria for CRT upgrade.

干预措施: Test Of The Frank Starling Mechanism - Adjustment Of Av Delay And Measurement Of Pre-load -Control (Other)

Control Group

Active Comparator

Control group: patients with an existing dual chamber pacemaker and with preserved ejection fraction

干预措施: Other: Test Of The Frank Starling Mechanism - Adjustment Of Av Delay And Measurement Of Pre-load -CRT (Other)

结局指标

主要结局

Difference in starling mechanism

时间窗: Prior to pacing test (starling mechanism test) and after six months

1\. Difference in maximum change in stroke volume (SV) in millilitres with AV delay modification "Starling mechanics" pre-CRT versus post-CRT (difference between lowest and highest SV).

次要结局

  • Left ventricular ejection fraction (%)(Prior to pacing test (starling mechanism test) and after six months)
  • Left ventricular end-systolic volume (ml)(Prior to pacing test (starling mechanism test) and after six months)
  • Quality of life with heart failure symptoms(Prior to pacing test (starling mechanism test) and after six months)
  • Packer's clinical composite score(Prior to pacing test (starling mechanism test) and at six months)
  • Difference in baseline Starling mechanics between CRT group and control group(Prior to pacing test (starling mechanism test) and at six months)
  • Heart failure symptoms(Prior to pacing test (starling mechanism test) and after six months)

研究者

申办方类型
Other
责任方
Sponsor

研究点 (2)

Loading locations...

相似试验